Screener
Tango Therapeutics TNGX Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Provision for income taxes | (1) | (34) |
| Net loss | $(45,514) | $(39,876) |
| Net loss per common share – basic and diluted | $(0.32) | $(0.36) |
| Weighted average number of common shares outstanding – basic and diluted | 143,576,292 | 110,301,256 |
| Net loss | $(45,514) | $(39,876) |
| Other comprehensive income (loss): | ||
| Unrealized (loss) gain on marketable securities | (339) | (142) |
| Comprehensive loss | $(45,853) | $(40,018) |
Item 1. Financial Statements.
FAQ
- What is Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Tango Therapeutics (TNGX) reported comprehensive income (loss), net of tax, attributable to parent of -$45.85M in Q1 2026.
- How has Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent decreased by 14.6% year-over-year, from -$40.02M to -$45.85M.
- What is the long-term trend for Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent has grown at a 14.6% compound annual growth rate (CAGR), from -$59.02M to -$101.71M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric captures changes in equity resulting from transactions and economic events other than those from transactions with owners. It includes unrealized gains or losses on available-for-sale securities, foreign currency translation adjustments, and other items that bypass the traditional net income statement. It provides a more holistic view of a company's financial health by accounting for volatility in asset valuations.
Ask your AI about Tango Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude